Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update

SAN DIEGO, May 11, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
May 09, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals Announces Initiation of Dosing in a Phase 1/2 Neoadjuvant Study of TRC105 in Patients with Breast Cancer

SAN DIEGO, May 09, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
May 04, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON to Report First Quarter 2016 Company Highlights and Financial Results on May 11, 2016

SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
May 04, 2016 08:00 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Announces EMA Orphan Drug Designation for TRC105 in Soft Tissue Sarcoma

SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
April 21, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Announces Clinical Data Presentations at Upcoming ASCO Annual Meeting

SAN DIEGO, April 21, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
April 11, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals Announces TRC105 Clinical Data Presentation at Upcoming AACR Annual Meeting

SAN DIEGO, April 11, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
April 05, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference

SAN DIEGO, April 05, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
March 21, 2016 08:00 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals Reports Updated Positive Data on Ongoing Complete Response in Choriocarcinoma Patient Treated with TRC105

SAN DIEGO, March 21, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
March 14, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals Initiates Phase 1b Study of TRC105 in Patients with Lung Cancer

SAN DIEGO, March 14, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
March 07, 2016 16:05 ET | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals to Present at the 28th Annual Roth Conference

SAN DIEGO, March 07, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...